Chemo-Immunotherapy, a Combination Approach for the Treatment of HER2-Positive Breast Cancer in a Mouse Model
Preprint in Research Square (February 2024)
The most recent citing publications are shown below. View all 113 publications that cite this research output on Dimensions.
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion
Article in International Journal of Molecular Sciences (December 2023)
Assessment of salivary levels of ErbB2 in oral squamous cell carcinoma.
Article in Journal of Oral and Maxillofacial Pathology (December 2023)